vTv Therapeutics Inc.VTVTNASDAQ
Loading
Operating Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank50
3Y CAGR-78.6%
5Y CAGR-60.7%
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

3Y CAGR
-78.6%/yr
vs -14.7%/yr prior
5Y CAGR
-60.7%/yr
Recent deceleration
Acceleration
-63.9pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
20250.21%
2024-32.63%
2023-25.15%
202221.04%
2021-7.27%
202021.80%
201914.29%
201839.73%
20177.57%
2016-30.49%